SLC4A2 and primary biliary cholangitis: This has been linked to increased expression of miRNA-506 in PBC cholangiocytes, which targets the mRNAs of AE2 [58] and type III inositol 1,4,5-trisphosphate receptor [59], both posttranscriptional inhibitions resulting in impaired biliary secretion.